Reported ESRD Period and Point Prevalence, Incidence, Death and Lost-to-Followup Counts, 1988-97 Counts (1000s) 361,031 307,967 Period Prev. Point Prev. Deaths Incidence 80,248 57,793 LFU** 22,264 * *Preliminary **Lost-to-Followup Year II -1 USRDS 1999

ESRD Prevalence Rates* and Annual Percent Change by Year, 1988-97 Rate/Million Pop./Year %Change Per Year Prevalence Rate % Change ** *Adjusted for sex, age, and race. **Preliminary Year II -2 USRDS 1999

ESRD Incidence Rates* and Annual Percent Change by Year, 1988-97 Rate/Million Pop./Year %Change Per Year X=Projected (3.5% increase expected from late reporting in 1997) Incidence Rate Possible reporting delay ( O=average for 2 years) % Change ** Year *Adjusted for sex, age, and race. **Preliminary II -3 USRDS 1999

ESRD Incidence and Prevalence Counts by Age Group, 1997* Counts II -4 *Preliminary USRDS 1999

ESRD Incidence Rates* by Age, 1988-97 Rate/Million Pop./Year Age 65-74 Age 75+ Age 45-64 Age 20-44 ** Year II -5 * Adjusted for sex and race ** Preliminary USRDS 1999

Median Age at Incidence for All ESRD Patients by Race, 1988-97 Median Age (years) 67 65 Native Am Total Black White 59 Asian * II -6 * Preliminary Year of Incidence USRDS 1999

ESRD Incidence Rates* by Race, 1988-97 Rate/Million Pop./Year †Rise and fall for 1995-97 may be a reporting anomaly Black Native Am† Asian† White ** Year *Adjusted for age and sex **Preliminary II -7 USRDS 1999

ESRD Incidence Rates* by Primary Diagnosis, 1988-97 Rate/Million Pop./Year Diabetes Hypertension Other Glomerulonephritis ** Year II -8 *Adjusted for age, sex, and race **Preliminary USRDS 1999